Zusammenfassung
Frontmatter -- Preface -- Contents -- List of Contributors -- List of Invited Active Participants -- 1. Methods for Detection of Tumor-Specific Sensitized Lymphocytes -- 1.1 Tumor-Specific and Cell-Mediated Immune Reactions Expressed in Pathomorphological Findings -- 1.2 Problems in Identifying Tumor-Specific Sensitized Lymphocytes -- 1.3 The Mixed Lymphocyte Tumor Cell Culture (MLTC) Test: Review of a Method -- 1.4 Lymphocyte Tansformation in Malignant Diseases. Communication I: Méthodologie Problems -- 1.5 Microcytotocicity Test for Detection of Cellular Immunity to Nephroblastoma in Man -- 1.6 Comparative Tumorimmunological Studies with the Microcytotoxicity Test and the DNA-Synthesis Inhibition Test -- 1.7 The Leukocyte Adherence Inhibition Test for Detection of Tumor-Specific Sensitized Lymphocytes and Serum Blocking Factors -- 2. Methods for Detection of Molecular Antibodies against Tumor Proteins -- 2.1 A Special Aspect of the Complement Fixation Test Applied to the Study of Tumors -- 2.2 Principle and Technique of the Lewis-3 D Test" for the Serological Diagnosis of Malignancy - A Critical Evaluation of the Results -- 3. Methods for Detection of Tumor Cell Surface Antigens -- 3.1 The Preparation and Application of Hybrid Antibody for the Detection of Tumor-Specific Cell Surface Antigens -- 3.2 In vitro Characterization of Avian Oncornavirus Directed Tumor Antigens -- 3.3 Tumor-Cell Membrane Antigens Related to Blood Group A Substances -- 3.4 Erythrocytic ABH-Receptors in Leukemia - An Immunofluorescence Study -- 3.5 Immunological Aspects of Placental Choriocarcioma -- 4. Methods for Detection of Non Tumor Antigens and Fetal Proteins -- 4.1 Non Tumor Antigens in Human Tumors -- 4.2 Detection of Alpha-1 Fetoprotein in Human Serum -- 4.3 Demonstration of Carcinoembryonic Antigens in Tumors of the Gastrointestinal Tract -- 4.4 Radioimmunoassay of CEA: Its Use in Diagnosis and Prognosis of Human Carcinoma -- 4.5 A Contribution for the Detection of Fetal Antigens in Serum of Tumor Patients -- 5. Methods for Detection of Proteins Excreted by Tumor Cells -- 5.1 Experiments to Induce Myeloma Protein-Forming Neoplasma in Rodents -- 5.2 Immunological Differentiation of Monoclonal Immunoglobulins -- 5.3 Lung Neoplasia and Paraproteinemia -- 6. Some Clinical Aspects -- 6.1 Lymphocyte Transformation in Malignant Diseases. Communication II: Results in Reticuloand Lymphoproliferative Diseases as well as in Carcinomas -- 6.2 Immunosuppressive Therapy with Antiiymphocytic Globulin and Tumor Formation -- 6.3 Behaviour of GUARINI Reaction in Children with Hemolymphoblastoses and non Tumoral Diseases -- References